PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human TRANCE (RANKL) (carrier-free), 500 μg
Recombinant Human TSLP (carrier-free), 10 μg
Recombinant Human TSLP (carrier-free), 100 μg
Recombinant Human TSLP (carrier-free), 25 μg
Recombinant Human TSLP (carrier-free), 500 μg
Recombinant Human Tumor Necrosis Factor-alpha, 50ug - CYT-223
Recombinant Human TWEAK (CD255) (carrier-free), 25 μg
Recombinant Human TWEAK (CD255) (carrier-free), 5 μg
Recombinant Human Twisted Gastrulation (TSG) (carrier-free), 10 μg
Recombinant Human Twisted Gastrulation (TSG) (carrier-free), 50 μg
Recombinant Human u-Plasminogen Activator (Urokinase) (carrier-free), 10 μg
Recombinant Human u-Plasminogen Activator (Urokinase) (carrier-free), 25 μg
Recombinant Human VAP-1 (carrier-free), 10 μg
Recombinant Human VAP-1 (carrier-free), 2 μg
Recombinant Human VCAM-1-Fc Chimera (carrier-free), 100 μg
Recombinant Human VCAM-1-Fc Chimera (carrier-free), 25 μg